{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:01:53Z","timestamp":1788850913889,"version":"build-2803163510"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.steroids.2017.10.010","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T12:03:33Z","timestamp":1510315413000},"page":"28-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Effect of 17\u03b2-estradiol on estrogen receptor negative breast cancer cells in an osteolytic mouse model"],"prefix":"10.1016","volume":"142","author":[{"given":"D. Joshua","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaidehi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara D.","family":"Boyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zvi","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"04","key":"10.1016\/j.steroids.2017.10.010_b0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4236\/ojapo.2014.34008","article-title":"Sensitivity evaluation of two human breast cancer cell lines to tamoxifen through apoptosis induction","volume":"03","author":"Keene","year":"2014","journal-title":"Open J, Apoptosis"},{"key":"10.1016\/j.steroids.2017.10.010_b0010","series-title":"SEER Cancer Statistics Review 1975\u20132009 (Vintage 2009 Populations)","author":"Howlader","year":"2012"},{"key":"10.1016\/j.steroids.2017.10.010_b0015","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1158\/0008-5472.CAN-06-0402","article-title":"Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes","volume":"66","author":"Sharma","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.steroids.2017.10.010_b0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/bcr2889","article-title":"Choosing the right cell line for breast cancer research","volume":"13","author":"Holliday","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.steroids.2017.10.010_b0025","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1038\/sj.onc.1209265","article-title":"Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics","volume":"25","author":"Nagaraja","year":"2006","journal-title":"Oncogene"},{"issue":"Pt 3","key":"10.1016\/j.steroids.2017.10.010_b0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.mce.2015.04.017","article-title":"Estrogen receptor alpha-36 (ER-alpha36): a new player in human breast cancer","volume":"418","author":"Wang","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.steroids.2017.10.010_b0035","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/j.bbamcr.2014.07.019","article-title":"Estrogen receptor-alpha 36 mediates the anti-apoptotic effect of estradiol in triple negative breast cancer cells via a membrane-associated mechanism","volume":"1843","author":"Chaudhri","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.steroids.2017.10.010_b0040","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1200\/JCO.2008.17.2254","article-title":"Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer","volume":"27","author":"Shi","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.steroids.2017.10.010_b0045","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.1074\/jbc.M111.292946","article-title":"Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-alpha36 (ERalpha36)","volume":"287","author":"Chaudhri","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2017.10.010_b0050","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3892\/etm.2011.226","article-title":"Analysis of estrogen receptor isoforms and variants in breast cancer cell lines","volume":"2","author":"Al-Bader","year":"2011","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.steroids.2017.10.010_b0055","first-page":"210","article-title":"Expression of estrogen receptor beta messenger RNA variant in breast cancer","volume":"58","author":"Vladusic","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.steroids.2017.10.010_b0060","doi-asserted-by":"crossref","first-page":"e0173931","DOI":"10.1371\/journal.pone.0173931","article-title":"Mammary epithelial cell phenotype disruption in vitro and in vivo through ERalpha36 overexpression","volume":"12","author":"Thiebaut","year":"2017","journal-title":"PLoS One"},{"issue":"79","key":"10.1016\/j.steroids.2017.10.010_b0065","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00280-016-3208-2","article-title":"Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205","author":"Zhang","year":"2017","journal-title":"Cancer Chemother. Pharmacol."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X17301903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X17301903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T09:34:37Z","timestamp":1550309677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X17301903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":13,"alternative-id":["S0039128X17301903"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2017.10.010","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of 17\u03b2-estradiol on estrogen receptor negative breast cancer cells in an osteolytic mouse model","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2017.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}